Global View Capital Management LLC Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Global View Capital Management LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 1,250 shares of the company's stock, valued at approximately $372,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of HCA. FMR LLC grew its stake in shares of HCA Healthcare by 322.3% in the third quarter. FMR LLC now owns 3,141,769 shares of the company's stock valued at $1,276,909,000 after buying an additional 2,397,883 shares in the last quarter. Principal Financial Group Inc. grew its position in HCA Healthcare by 120.1% in the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company's stock valued at $262,264,000 after acquiring an additional 476,756 shares in the last quarter. Meritage Group LP purchased a new position in shares of HCA Healthcare in the third quarter valued at approximately $150,548,000. Raymond James Financial Inc. purchased a new stake in HCA Healthcare during the 4th quarter worth approximately $74,121,000. Finally, Canoe Financial LP grew its stake in shares of HCA Healthcare by 226,952.9% in the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company's stock worth $69,513,000 after acquiring an additional 231,492 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by company insiders.

Remove Ads

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded up $1.84 on Thursday, reaching $314.71. The company's stock had a trading volume of 957,126 shares, compared to its average volume of 1,719,359. The stock has a market capitalization of $77.48 billion, a P/E ratio of 14.32, a PEG ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The stock's 50-day moving average is $318.53 and its two-hundred day moving average is $346.05. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the company earned $5.90 EPS. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.92%. HCA Healthcare's payout ratio is 13.11%.

Analysts Set New Price Targets

Several research firms recently commented on HCA. Morgan Stanley lowered their target price on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research note on Tuesday, December 17th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Cantor Fitzgerald reissued an "overweight" rating and issued a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. Finally, Truist Financial lowered their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.